✦ LIBER ✦

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

✍ Scribed by Oh, Chad K ;Leigh, Richard ;McLaurin, Kimmie K ;Kim, Keunpyo ;Hultquist, Micki ;Molfino, Nestor A

Book ID: 121620700
Publisher: BMJ
Year: 2013
Tongue: English
Weight: 228 KB
Volume: 14
Category: Article
ISSN: 2052-4439
DOI: 10.1186/1465-9921-14-93

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic benefit of blocking interleu

Therapeutic benefit of blocking interleukin-6 activity with an anti–interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial

✍ E. H. S. Choy; D. A. Isenberg; T. Garrood; S. Farrow; Y. Ioannou; H. Bird; N. Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

[American Thoracic Society American Thor

[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] B33. ASTHMA THERAPY: NOVEL APPROACHES - A Phase 2b, Randomized Study To Evaluate The Clinical Activity And Safety Profile Of Subcutaneous MEDI-528, An Anti-IL-9 Monoclonal Antibody, In Adults With Uncontrolled Asthma

✍ Oh, Chad K.; McLaurin, Kimmie K.; Kim, Keunpyo; Hultquist, Micki; Molfino, Nesto 📂 Article 📅 2012 🏛 American Thoracic Society ⚖ 19 KB

Safety profile and clinical activity of

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

✍ Joseph M Parker; Chad K Oh; Craig LaForce; S David Miller; David S Pearlman; Che 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 361 KB

Rationale and design of a placebo-contro

Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of the human anti-TNF-α monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn’s disease

✍ Stephen Hanauer; Milan Lukáš; Donald MacIntosh; Paul Rutgeerts; William Sandborn 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A randomized controlled trial to evaluat

A randomized controlled trial to evaluate the effect of incorporating peanuts into an American Diabetes Association meal plan on the nutrient profile of the total diet and cardiometabolic parameters of adults with type 2 diabetes

✍ Wien, Michelle; Oda, Keiji; Sabaté, Joan 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 335 KB